# Propanc Biopharma, Inc.: Form 8-K, filed May 8, 2025

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 8-K
- Filed: 2025-05-08
- Accepted by EDGAR: May 7, 2025, 21:56 ET
- Period: 2025-05-07
- Accession: 0001641172-25-009121
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225009121/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000164117225009121/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000164117225009121/form8-k.htm

Filed May 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-009121. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.